πŸ•΅οΈ Supernus Pharmaceuticals, Inc. ($SUPN)

SEC insider & ownership activity, last 12 months Β· CIK 1356576 Β· every row links its SEC filing

Over the last 12 months insiders sold $19.7M with no open-market buying against it. Jack A. Khattar sold $9.9M through a program of 7 sale notices averaging $1.1M (Sep–Mar). No red-flag 8-Ks in the window.

🚨 7 signals active β€” planned-vs-executed verdicts, pre-event flags, and cluster context live in the API and the alerts bot.
Oct 2025: net -$6.3M Nov 2025: net +$0 Dec 2025: net -$1.0M Jan 2026: net +$0 Feb 2026: net -$228K Mar 2026: net -$9.0M Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0 Aug 2026: net +$0 Sep 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) Β· 8 sellers, $19.7M (30 lots)

InsiderBuysBoughtSellsSoldLast
Jack A. Khattar0– 11$9.9MMar 13, 2026
Padmanabh P. Bhatt0– 7$5.4MMar 18, 2026
Charles Newhall0– 2$1.3MOct 9, 2025
Frank Mottola0– 3$1.1MMar 9, 2026
Gemayel Georges0– 2$1.0MMar 6, 2026
William Todd Horich0– 2$484KMar 10, 2026
Frederick M. Hudson0– 1$272KMar 12, 2026
Sensenig Bethany0– 2$228KFeb 19, 2026

5%+ holders

HolderStakeClassScheduleEvent
BlackRock, Inc. 14.7% 13GApr 22, 2025 filing β†—
Millennium Management LLC 6.6% 13GAug 6, 2026 filing β†—
Millennium Group Management LLC 6.6% 13GAug 6, 2026 filing β†—
Israel A. Englander 6.6% 13GAug 6, 2026 filing β†—
Integrated CORE Strategies (US) LLC 6.2% 13GAug 6, 2026 filing β†—
Vanguard Portfolio Management 5.7% 13GApr 29, 2026 filing β†—
Vanguard Capital Management 5.0% 13GApr 30, 2026 filing β†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Padmanabh P. Bhatt$2.9MMar 17, 2026 filing β†—
Padmanabh P. Bhatt$2.5MMar 16, 2026 filing β†—
The KBT Trust U/A DTD 12/30/2010$1.8MMar 13, 2026 filing β†—
Frederick M. Hudson$272KMar 12, 2026 filing β†—
William Todd Horich$244KMar 10, 2026 filing β†—
William Todd Horich$240KMar 9, 2026 filing β†—
Frank Mottola$87KMar 9, 2026 filing β†—
Georges Gemayel$466KMar 6, 2026 filing β†—
Georges Gemayel$537KMar 5, 2026 filing β†—
Bethany Sensenig$225KFeb 19, 2026 filing β†—
Frank Mottola$986KDec 19, 2025 filing β†—
Jack A. Khattar$2.9MOct 9, 2025 filing β†—
Charles Newhall$1.2MOct 9, 2025 filing β†—
Jack A. Khattar$91KOct 2, 2025 filing β†—
Jack A. Khattar$1.9MOct 1, 2025 filing β†—
Jack A. Khattar$409KSep 30, 2025 filing β†—
Jack A. Khattar$481KSep 29, 2025 filing β†—
Jack A. Khattar$1.4MSep 23, 2025 filing β†—
Jack A. Khattar$764KSep 22, 2025 filing β†—

Material events (8-K)

ItemEvent date
Earnings (2.02)Aug 3, 2026 filing β†—
Financial Statements and Exhibits (9.01)Aug 3, 2026 filing β†—
Other events (8.01)Aug 3, 2026 filing β†—
Financial Statements and Exhibits (9.01)Aug 3, 2026 filing β†—
Other events (8.01)Aug 3, 2026 filing β†—
Financial Statements and Exhibits (9.01)Aug 3, 2026 filing β†—
Material agreement (1.01)Aug 1, 2026 filing β†—
Officer/director changes (5.02)Aug 1, 2026 filing β†—
Other events (8.01)Aug 1, 2026 filing β†—
Financial Statements and Exhibits (9.01)Aug 1, 2026 filing β†—
Earnings (2.02)Jul 22, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jul 22, 2026 filing β†—
Shareholder vote (5.07)Jun 18, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jun 18, 2026 filing β†—
New financial obligation (2.03)May 17, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 17, 2026 filing β†—
Earnings (2.02)May 5, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 5, 2026 filing β†—
Earnings (2.02)Apr 22, 2026 filing β†—
Material agreement (1.01)Apr 1, 2026 filing β†—
Acquisition or disposition (2.01)Apr 1, 2026 filing β†—
Financial Statements and Exhibits (9.01)Apr 1, 2026 filing β†—
Officer/director changes (5.02)Feb 24, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 24, 2026 filing β†—
Earnings (2.02)Feb 24, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 24, 2026 filing β†—
Earnings (2.02)Feb 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jan 28, 2026 filing β†—
Earnings (2.02)Nov 4, 2025 filing β†—